Relapse prevention in first-episode schizophrenia: role of long-acting injectables


Relapse risk factors
Use of LAIs in first-episode schizophrenia
LAI vs. oral antipsychotics
Use of aripiprazole once-monthly
Current recommendations for LAI use
Comment by Dr. Marc-André Roy

The clinical goals in the management of schizophrenia are to reduce the severity and duration of acute episodes of psychosis, promote recovery, maintain optimal functioning and prevent subsequent relapses (National Institute for Clinical Excellence, Clinical Practice Guidelines, No. 82;2009:210; Falkai et al. World J Biol Psychiatry 2006;7:5-4; Lehman et al. Am J Psychiatry 2004;161[suppl 2]:1-56).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page